Covera-hs and Mitral valve prolapse - a phase IV clinical study of FDA data

Summary:

Mitral valve prolapse is reported as a side effect among people who take Covera-hs (verapamil hydrochloride), especially for people who are female, 60+ old, also take Glucophage, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Mitral valve prolapse when taking Covera-hs. It is created by eHealthMe based on reports of 809 people who have side effects when taking Covera-hs from the FDA, and is updated regularly.

What is Covera-hs?

Covera-hs has active ingredients of verapamil hydrochloride. eHealthMe is studying from 823 Covera-hs users. Check the latest studies of Covera-hs.

What is Mitral valve prolapse?

Mitral valve prolapse (heart's mitral valve doesn't work well) is found to be associated with 504 drugs and 859 conditions by eHealthMe. Check the latest studies of Mitral valve prolapse.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

809 people reported to have side effects when taking Covera-hs.
Among them, 12 people (1.48%) have Mitral valve prolapse.

Could Covera-hs cause Mitral valve prolapse?

Among these 12 people:

What is the gender of people who have Mitral valve prolapse when taking Covera-hs? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Mitral valve prolapse when taking Covera-hs? *

What are other drugs people take besides Covera-hs? *

What are other side effects people have besides Mitral valve prolapse? *

Joint Swelling: 12 people, 100.00%
Enlarged Heart: 12 people, 100.00%
Facet Joint Syndrome (problem with movement of the facet joints of the spine): 12 people, 100.00%
Fall: 12 people, 100.00%
Fluid Overload (too much fluid in the blood): 12 people, 100.00%
Gallstones (stone formation by bile component): 12 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 100.00%
Gingival Erythema (redness of gums): 12 people, 100.00%
Gingival Pain (gum pain): 12 people, 100.00%
Haematoma (collection of blood outside the blood vessels): 12 people, 100.00%

What are the existing conditions these people have? *

Metastatic Neoplasm (spreadable cancer tumour): 12 people, 100.00%
Hypersensitivity: 12 people, 100.00%
Diabetes: 12 people, 100.00%
Breast Cancer Metastatic: 12 people, 100.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Covera-hs and have Mitral valve prolapse?

- Check whether Mitral valve prolapse is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Covera-hs:

Covera-hs (823 reports)

Browse all side effects of Covera-hs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mitral valve prolapse:

Mitral valve prolapse (504 drugs)

Browse all the conditions that are associated with Mitral valve prolapse:

Mitral valve prolapse (859 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride (the active ingredients of Covera-hs) and Covera-hs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.